| Target Price | $20.40 |
| Price | $13.94 |
| Potential |
46.34%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target NeuroPace Inc 2027 .
The average NeuroPace Inc target price is $20.40.
This is
46.34%
register free of charge
$23.10
65.71%
register free of charge
$18.18
30.42%
register free of charge
|
|
| A rating was issued by 15 analysts: 14 Analysts recommend NeuroPace Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the NeuroPace Inc stock has an average upside potential 2027 of
46.34%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 99.99 | 102.29 |
| 25.13% | 2.30% | |
| EBITDA Margin | -16.10% | -8.62% |
| 40.04% | 46.46% | |
| Net Margin | -21.47% | -20.70% |
| 36.78% | 3.60% |
11 Analysts have issued a sales forecast NeuroPace Inc 2026 . The average NeuroPace Inc sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an NeuroPace Inc EBITDA forecast 2026. The average NeuroPace Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 NeuroPace Inc Analysts have issued a net profit forecast 2026. The average NeuroPace Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.66 | -0.62 |
| 29.03% | 6.06% | |
| P/E | negative | |
| EV/Sales | 4.82 |
11 Analysts have issued a NeuroPace Inc forecast for earnings per share. The average NeuroPace Inc EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Keybanc |
Locked
➜
Locked
|
Locked | Sep 18 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 29 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 15 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 27 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Dec 16 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Keybanc:
Locked
➜
Locked
|
Sep 18 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 29 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 15 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 27 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Dec 16 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Dec 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


